**Rating**: Hold **Executive Summary**: Maintain current WMT positions at existing weightings with no directional add or trim. For new capital, deploy a small 25% starter tranche at the current $103 level with a hard stop at $100, then add the remaining 75% only upon a confirmed…

**Rating**: Hold **Executive Summary**: Maintain current XOM position at the prevailing 3-5% allocation near $156.71 with no new capital deployment. Tighten the stop to $149.40 (lower Bollinger Band / 50 SMA confluence) rather than the wider $141.91 200-SMA stop to cap downside …

**Rating**: Hold **Executive Summary**: Maintain UNH at benchmark-neutral (market-weight) allocation. Do not add or trim meaningfully at $392.95 given the unresolved tension between the bull's V-shaped recovery thesis and the bear's structural margin compression case. The decisi…

**Rating**: Overweight **Executive Summary**: Maintain/initiate an Overweight posture on V through disciplined, staged accumulation rather than chasing at current levels near ~$381.60. Deploy an initial tranche of only ~20% of the planned position at the $365-368 pullback zone (…

**Rating**: Hold **Executive Summary**: Maintain the current NVDA position at ~$217 with no adds or trims. Keep the defined risk framework: add no more than 25% of current position only on a clean break above the $228 resistance zone on above-average volume, and reduce exposure …

**Rating**: Underweight **Executive Summary**: Reduce NEE exposure by 25-35% via a phased execution: trim ~15-20% immediately at market (~$81.84) to acknowledge the confirmed technical breakdown and escalating regulatory overhang, then layer the remaining ~10-15% via limit order…

**Rating**: Hold **Executive Summary**: Maintain the current JPM position at the 5% portfolio cap; do not add at 52-week highs near $357 and do not trim into a still-bullish long-term trend. Keep the core position fully exposed while setting disciplined triggers: begin staged ac…

**Rating**: Hold **Executive Summary**: Maintain MSFT at current position sizing without adding or trimming at these levels near $513. Execute a dynamic, trigger-based accumulation plan: place buy limits at $498 (below 10-EMA/VWMA support) and $485 (prior consolidation zone), wi…

**Rating**: Hold **Executive Summary**: Maintain the current core CVX position (5-8% max) at ~$201.86 without adding or trimming. Do not chase new exposure after the 27% two-month run with price extended well above the 50-SMA and MACD flashing bearish. For new capital, trigger e…

**Rating**: Hold **Executive Summary**: Maintain existing COST positions at current allocation (market weight, no more than 5% of portfolio). Do not add new capital without confirmation of trend reversal—specifically either a close above $975 on meaningful volume or a sustained …